Transcriptomics

Dataset Information

0

Targeting MYC induces lipid droplet accumulation by upregulation of HILPDA in clear cell renal cell carcinoma


ABSTRACT: Metabolic reprogramming is critical during clear cell renal cell carcinoma (ccRCC) tumorigenesis, manifested by accumulation of lipid droplets (LDs), organelles that have emerged as new hallmarks of cancer. Yet, regulation of their biogenesis is still poorly understood. Here, we demonstrate that MYC inhibition in ccRCC cells lacking the von Hippel Lindau (VHL) gene leads to increased triglyceride content potentiating LD formation in a glutamine-dependent manner. Notably, LD accumulation is prevented, and tumor burden reduced in vivo upon concurrent inhibition of MYC signaling and glutamine metabolism. Furthermore, we identified the hypoxia inducible lipid droplet associated protein (HILPDA) as the key driver for induction of MYC-driven LD accumulation and demonstrated that conversely, proliferation, LD formation, and tumor growth are impaired upon its downregulation. Finally, analysis of ccRCC tissue as well as healthy renal control samples, postulated HILPDA as a specific ccRCC biomarker. Together, these discoveries provide an attractive approach for development of new therapeutic interventions for the treatment of this type of renal cancer.

ORGANISM(S): Homo sapiens

PROVIDER: GSE223069 | GEO | 2024/01/27

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2021-11-10 | GSE187470 | GEO
2019-12-19 | GSE142295 | GEO
2019-12-19 | GSE142294 | GEO
| PRJNA924799 | ENA
2020-01-01 | GSE126002 | GEO
2024-05-15 | GSE267069 | GEO
2012-06-08 | E-GEOD-38590 | biostudies-arrayexpress
2022-03-01 | PXD001552 | Pride
2012-06-09 | GSE38590 | GEO
2021-03-29 | PXD023047 | Pride